Literature DB >> 18292230

Akt and CHIP coregulate tau degradation through coordinated interactions.

Chad A Dickey1, John Koren, Yong-Jie Zhang, Ya-Fei Xu, Umesh K Jinwal, Morris J Birnbaum, Bobby Monks, Mei Sun, Jin Q Cheng, Cam Patterson, Rachel M Bailey, Judith Dunmore, Sareh Soresh, Carlos Leon, Dave Morgan, Leonard Petrucelli.   

Abstract

A hallmark of the pathology of Alzheimer's disease is the accumulation of the microtubule-associated protein tau into fibrillar aggregates. Recent studies suggest that they accumulate because cytosolic chaperones fail to clear abnormally phosphorylated tau, preserving a pool of toxic tau intermediates within the neuron. We describe a mechanism for tau clearance involving a major cellular kinase, Akt. During stress, Akt is ubiquitinated and degraded by the tau ubiquitin ligase CHIP, and this largely depends on the Hsp90 complex. Akt also prevents CHIP-induced tau ubiquitination and its subsequent degradation, either by regulating the Hsp90/CHIP complex directly or by competing as a client protein with tau for binding. Akt levels tightly regulate the expression of CHIP, such that, as Akt levels are suppressed, CHIP levels also decrease, suggesting a potential stress response feedback mechanism between ligase and kinase activity. We also show that Akt and the microtubule affinity-regulating kinase 2 (PAR1/MARK2), a known tau kinase, interact directly. Akt enhances the activity of PAR1 to promote tau hyperphosphorylation at S262/S356, a tau species that is not recognized by the CHIP/Hsp90 complex. Moreover, Akt1 knockout mice have reduced levels of tau phosphorylated at PAR1/MARK2 consensus sites. Hence, Akt serves as a major regulator of tau biology by manipulating both tau kinases and protein quality control, providing a link to several common pathways that have demonstrated dysfunction in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18292230      PMCID: PMC2265134          DOI: 10.1073/pnas.0709180105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  The Sch9 protein kinase regulates Hsp90 chaperone complex signal transduction activity in vivo.

Authors:  K A Morano; D J Thiele
Journal:  EMBO J       Date:  1999-11-01       Impact factor: 11.598

2.  CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation.

Authors:  Leonard Petrucelli; Dennis Dickson; Kathryn Kehoe; Julie Taylor; Heather Snyder; Andrew Grover; Michael De Lucia; Eileen McGowan; Jada Lewis; Guy Prihar; Jungsu Kim; Wolfgang H Dillmann; Susan E Browne; Alexis Hall; Richard Voellmy; Yoshio Tsuboi; Ted M Dawson; Benjamin Wolozin; John Hardy; Mike Hutton
Journal:  Hum Mol Genet       Date:  2004-02-12       Impact factor: 6.150

Review 3.  Hsp90 inhibitors as novel cancer chemotherapeutic agents.

Authors:  Len Neckers
Journal:  Trends Mol Med       Date:  2002       Impact factor: 11.951

4.  The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins.

Authors:  Chad A Dickey; Adeela Kamal; Karen Lundgren; Natalia Klosak; Rachel M Bailey; Judith Dunmore; Peter Ash; Sareh Shoraka; Jelena Zlatkovic; Christopher B Eckman; Cam Patterson; Dennis W Dickson; N Stanley Nahman; Michael Hutton; Francis Burrows; Leonard Petrucelli
Journal:  J Clin Invest       Date:  2007-02-15       Impact factor: 14.808

5.  Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein + presenilin-1 transgenic mice.

Authors:  Chad A Dickey; Jeanne F Loring; Julia Montgomery; Marcia N Gordon; P Scott Eastman; Dave Morgan
Journal:  J Neurosci       Date:  2003-06-15       Impact factor: 6.167

6.  Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function.

Authors:  Andrea D Basso; David B Solit; Gabriela Chiosis; Banabihari Giri; Philip Tsichlis; Neal Rosen
Journal:  J Biol Chem       Date:  2002-08-09       Impact factor: 5.157

7.  Regulation of longevity in Caenorhabditis elegans by heat shock factor and molecular chaperones.

Authors:  James F Morley; Richard I Morimoto
Journal:  Mol Biol Cell       Date:  2003-12-10       Impact factor: 4.138

8.  PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila.

Authors:  Isao Nishimura; Yufeng Yang; Bingwei Lu
Journal:  Cell       Date:  2004-03-05       Impact factor: 41.582

9.  CHIP activates HSF1 and confers protection against apoptosis and cellular stress.

Authors:  Qian Dai; Chunlian Zhang; Yaxu Wu; Holly McDonough; Ryan A Whaley; Virginia Godfrey; Hui-Hua Li; Nageswara Madamanchi; Wanping Xu; Len Neckers; Douglas Cyr; Cam Patterson
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

10.  Timing requirements for insulin/IGF-1 signaling in C. elegans.

Authors:  Andrew Dillin; Douglas K Crawford; Cynthia Kenyon
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

View more
  98 in total

Review 1.  Emerging role of Lys-63 ubiquitination in protein kinase and phosphatase activation and cancer development.

Authors:  W-L Yang; X Zhang; H-K Lin
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

2.  E2 conjugating enzyme selectivity and requirements for function of the E3 ubiquitin ligase CHIP.

Authors:  Sarah E Soss; Yuanyuan Yue; Sirano Dhe-Paganon; Walter J Chazin
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

3.  Akt is negatively regulated by the MULAN E3 ligase.

Authors:  Seunghee Bae; Sun-Yong Kim; Jin Hyuk Jung; Yeongmin Yoon; Hwa Jun Cha; Hyunjin Lee; Karam Kim; Jongran Kim; In-Sook An; Jongdoo Kim; Hong-Duck Um; In-Chul Park; Su-Jae Lee; Seon Young Nam; Young-Woo Jin; Jae Ho Lee; Sungkwan An
Journal:  Cell Res       Date:  2012-03-13       Impact factor: 25.617

Review 4.  Regulation of proteasome activity in health and disease.

Authors:  Marion Schmidt; Daniel Finley
Journal:  Biochim Biophys Acta       Date:  2013-08-27

Review 5.  Therapeutic Strategies for Restoring Tau Homeostasis.

Authors:  Zapporah T Young; Sue Ann Mok; Jason E Gestwicki
Journal:  Cold Spring Harb Perspect Med       Date:  2018-01-02       Impact factor: 6.915

6.  Rho-kinase ROCK inhibitors reduce oligomeric tau protein.

Authors:  Tadanori Hamano; Norimichi Shirafuji; Shu-Hui Yen; Hirotaka Yoshida; Nicholas M Kanaan; Kouji Hayashi; Masamichi Ikawa; Osamu Yamamura; Youshi Fujita; Masaru Kuriyama; Yasunari Nakamoto
Journal:  Neurobiol Aging       Date:  2019-12-16       Impact factor: 4.673

7.  Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.

Authors:  Monica Javidnia; Michaeline L Hebron; Yue Xin; Nikolas G Kinney; Charbel E-H Moussa
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

8.  CHIP represses myocardin-induced smooth muscle cell differentiation via ubiquitin-mediated proteasomal degradation.

Authors:  Ping Xie; Yongna Fan; Hua Zhang; Yuan Zhang; Mingpeng She; Dongfeng Gu; Cam Patterson; Huihua Li
Journal:  Mol Cell Biol       Date:  2009-02-23       Impact factor: 4.272

9.  Aging analysis reveals slowed tau turnover and enhanced stress response in a mouse model of tauopathy.

Authors:  Chad Dickey; Clara Kraft; Umesh Jinwal; John Koren; Amelia Johnson; Laura Anderson; Lori Lebson; Daniel Lee; Dennis Dickson; Rohan de Silva; Lester I Binder; David Morgan; Jada Lewis
Journal:  Am J Pathol       Date:  2008-12-12       Impact factor: 4.307

10.  Changes in proteome solubility indicate widespread proteostatic disruption in mouse models of neurodegenerative disease.

Authors:  Michael C Pace; Guilian Xu; Susan Fromholt; John Howard; Keith Crosby; Benoit I Giasson; Jada Lewis; David R Borchelt
Journal:  Acta Neuropathol       Date:  2018-08-23       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.